Pancreatic cancer early detection and high-risk programs

On this episode of Living Hope: Your Journey with Pancreatic Cancer, we welcome Dr. Michael Demeure, Medical Director of Precision Medicine at Hoag Family Cancer Institute.

Dr. Demeure explains how precision medicine—using DNA sequencing to identify genetic drivers of cancer—can help doctors choose more effective treatments with fewer side effects. He discusses the importance of early detection and Hoag’s High-Risk Pancreatic Cancer Program, which screens patients with inherited mutations or family history using advanced tools like MRI and endoscopic ultrasound.

We explore how genetic testing benefits both patients and their families, the role of tumor boards in guiding treatment decisions, and promising research on AI, vaccines, and engineered immune cells. Dr. Demeure also shares his journey into precision medicine and why he is passionate about advancing pancreatic cancer care.

For information on Proceed Medicine visit www.precedestudy.org